As shown in Figure 3, the expression levels of CD2AP, GRB2, WASL, and CAPZA1 are generally downregulated, while those of SRC and CTTN are upregulated in colon cancer samples compared with their levels in normal samples at the RNA and/or protein levels. Here, GRB2 is linked to malignant colon neoplasm.